Baidu
map

Clin Nutrition: 饮食中维生素C和E的含量对帕金森氏病风险的影响

2021-05-23 MedSci原创 MedSci原创

近日,有研究显示摄入富含维生素C和维生素E食物的人患帕金森疾病(PD)的风险或会降低近三分之一。富含维生素C的食物包括橙子、草莓、花椰菜和球芽甘蓝。

      近日,有研究显示摄入富含维生素C和维生素E食物的人患帕金森疾病(PD)的风险或会降低近三分之一。富含维生素C的食物包括橙子、草莓、花椰菜和球芽甘蓝;富含维生素E的食物包括菠菜、羽衣甘蓝、南瓜和坚果(比如花生和杏仁等)。研究人员表示,维生素C和E均是能有效抑制帕金森疾病诱发细胞损伤的抗氧化剂,具体而言,抗氧化剂能够帮助抵御不稳定的分子以及氧化性压力,这些氧化性压力会导致成为多巴胺的大脑化学物质的损失,这是帕金森疾病发生的主要标志。因此,摄入富含这两种维生素的食物或能帮助预防帕金森疾病的发生。此外,研究人员还在中枢神经系统中发现了高浓度的维生素C,在中枢神经系统中其能发挥神经保护的特性。

 

      研究人员对所有使用PubMed,EMBASE,Cochrane和SCOPUS数据库进行了全面的文献检索,以研究截止到2021年1月23日发表的相关研究。总共纳入了12项研究(四项前瞻性队列研究和八项病例对照研究)。研究结果显示 与低摄入量组相比,高维生素C摄入量组未观察到明显的风险降低。另一方面,高维生素E摄入组的PD发生风险明显低于低维生素E组(OR =0.799。95%CI = 0.721-0.885)。

 

       很多患者都会摄入抗氧化剂补充剂,其中也有很多患者会摄入维生素C和E,这样做对其机体健康是非常有益的;存在帕金森疾病风险的人群或会因摄入抗氧化剂而获益;尤其是那些有疾病家族史的人群。保护机体免于帕金森疾病最好的方式就是拥有健康的生活方式,包括摄入富含水果、蔬菜和全谷类的地中海饮食方式,同时进行足够的锻炼。

 

 

原始出处:

Min Cheol Chang. Et al. Effect of Dietary Vitamins C and E on The Risk of Parkinson’s Disease: A Meta-Analysis. Clinical Nutrition.2021.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1185208, encodeId=03611185208b9, content=也许有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Jan 17 15:20:29 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661640, encodeId=a2ac16616404f, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Mon Jan 17 22:56:14 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968107, encodeId=0ca796810e19, content=受益匪浅 , beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e55506719, createdName=ms2000001800821858, createdTime=Mon May 24 10:37:10 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967957, encodeId=de2b96e957af, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:07:11 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967918, encodeId=17ec96e91892, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56fd5489891, createdName=ms3000000425377841, createdTime=Sun May 23 14:31:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967912, encodeId=802b96e9125a, content=已读,真是受益匪浅呀。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun May 23 13:35:41 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2022-01-17 shirly.li19560809

    也许有道理

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1185208, encodeId=03611185208b9, content=也许有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Jan 17 15:20:29 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661640, encodeId=a2ac16616404f, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Mon Jan 17 22:56:14 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968107, encodeId=0ca796810e19, content=受益匪浅 , beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e55506719, createdName=ms2000001800821858, createdTime=Mon May 24 10:37:10 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967957, encodeId=de2b96e957af, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:07:11 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967918, encodeId=17ec96e91892, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56fd5489891, createdName=ms3000000425377841, createdTime=Sun May 23 14:31:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967912, encodeId=802b96e9125a, content=已读,真是受益匪浅呀。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun May 23 13:35:41 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1185208, encodeId=03611185208b9, content=也许有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Jan 17 15:20:29 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661640, encodeId=a2ac16616404f, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Mon Jan 17 22:56:14 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968107, encodeId=0ca796810e19, content=受益匪浅 , beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e55506719, createdName=ms2000001800821858, createdTime=Mon May 24 10:37:10 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967957, encodeId=de2b96e957af, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:07:11 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967918, encodeId=17ec96e91892, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56fd5489891, createdName=ms3000000425377841, createdTime=Sun May 23 14:31:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967912, encodeId=802b96e9125a, content=已读,真是受益匪浅呀。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun May 23 13:35:41 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2021-05-24 ms2000001800821858

    受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1185208, encodeId=03611185208b9, content=也许有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Jan 17 15:20:29 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661640, encodeId=a2ac16616404f, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Mon Jan 17 22:56:14 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968107, encodeId=0ca796810e19, content=受益匪浅 , beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e55506719, createdName=ms2000001800821858, createdTime=Mon May 24 10:37:10 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967957, encodeId=de2b96e957af, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:07:11 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967918, encodeId=17ec96e91892, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56fd5489891, createdName=ms3000000425377841, createdTime=Sun May 23 14:31:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967912, encodeId=802b96e9125a, content=已读,真是受益匪浅呀。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun May 23 13:35:41 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2021-05-23 jyzxjiangqin

    好好学习!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1185208, encodeId=03611185208b9, content=也许有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Jan 17 15:20:29 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661640, encodeId=a2ac16616404f, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Mon Jan 17 22:56:14 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968107, encodeId=0ca796810e19, content=受益匪浅 , beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e55506719, createdName=ms2000001800821858, createdTime=Mon May 24 10:37:10 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967957, encodeId=de2b96e957af, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:07:11 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967918, encodeId=17ec96e91892, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56fd5489891, createdName=ms3000000425377841, createdTime=Sun May 23 14:31:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967912, encodeId=802b96e9125a, content=已读,真是受益匪浅呀。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun May 23 13:35:41 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2021-05-23 ms3000000425377841

    受益匪浅

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1185208, encodeId=03611185208b9, content=也许有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Jan 17 15:20:29 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661640, encodeId=a2ac16616404f, content=<a href='/topic/show?id=1b3c1315481' target=_blank style='color:#2F92EE;'>#nutrition#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13154, encryptionId=1b3c1315481, topicName=nutrition)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d25331316, createdName=膀胱癌, createdTime=Mon Jan 17 22:56:14 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968107, encodeId=0ca796810e19, content=受益匪浅 , beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e55506719, createdName=ms2000001800821858, createdTime=Mon May 24 10:37:10 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967957, encodeId=de2b96e957af, content=好好学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:07:11 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967918, encodeId=17ec96e91892, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56fd5489891, createdName=ms3000000425377841, createdTime=Sun May 23 14:31:33 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967912, encodeId=802b96e9125a, content=已读,真是受益匪浅呀。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun May 23 13:35:41 CST 2021, time=2021-05-23, status=1, ipAttribution=)]
    2021-05-23 ms5000000518166734

    已读,真是受益匪浅呀。

    0

相关资讯

IEEE trans:哈希转换和机器学习的决策分类器提高了帕金森病筛查的准确率

帕金森病(Parkinson’s disease,PD)是一种常见的神经系统变性疾病,老年人多见,平均发病年龄为60岁左右,40岁以下起病的青年帕金森病较少见。我国65岁以上人群PD的患病

JAMA Netw Open:梦游者患帕金森病风险比常人高出4倍!

自1990年以来,帕金森病(PD)是全球患病率,致残率和死亡率增长最快的神经系统疾病。

世界帕金森病日|陈生弟教授谈帕金森病的诊疗现状和新近进展

每年的4月11日是世界帕金森病日。帕金森病是一种常见的中老年神经系统退行性疾病,我国65岁以上人群帕金森病的患病率为1700/10万1,与西方国家相似。由于我国人口基数大,因此,帕金森病患者群体庞大。

Ann Neurol:纳比龙可有效且安全的治疗伴非运动症状的帕金森病患者

帕金森病(PD)的非运动症状(NMS)包括自主神经系统功能障碍、嗅觉丧失、情绪和认知障碍,以及睡眠问题,如失眠、白天嗜睡或快速眼动(REM)睡眠行为障碍。NMS是决定PD患者生活质量、进行性残疾和依赖

J Neuroeng Rehabil:个性化定制的互动视频游戏训练可以改善轻中度帕金森病老年患者运动能力

帕金森病(Parkinson's disease,PD)是影响老年人的第二大常见神经退行性疾病。 运动项目有利于PD患者,在一定程度上改善体力和功能、与健康相关的生活质量、平衡和步态速度。然而,大多数

Neurology:经常运动人,认知能力更好!

经常运动人,认知能力更好!

Baidu
map
Baidu
map
Baidu
map